Russia has developed an mRNA-based vaccine aimed at combating cancer. The vaccine, developed in collaboration with multiple research centres, is set to be distributed free of cost to cancer patients, as announced by Andrey Kaprin, General Director of the Radiology Medical Research Center under the Russian Ministry of Health. This vaccine is expected to be released for public use by early 2025. Pre-clinical trials have already demonstrated its efficacy in suppressing tumour development and preventing potential metastases, according to Alexander Gintsburg, Director of the Gamaleya National Research Center for Epidemiology and Microbiology. mRNA vaccines work by delivering specific instructions to...